相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value
Esther Janssens et al.
ACTA CLINICA BELGICA (2023)
Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
Lindsay R. Grant et al.
CLINICAL INFECTIOUS DISEASES (2023)
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A
Li Hao et al.
VACCINE (2022)
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
Germaine Hanquet et al.
EMERGING INFECTIOUS DISEASES (2022)
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A
Li Hao et al.
VACCINE (2022)
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
Donald Hurley et al.
CLINICAL INFECTIOUS DISEASES (2021)
Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean
Cynthia G. Whitney et al.
LANCET INFECTIOUS DISEASES (2021)
Effectiveness of the 7-and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2021)
1181. Serotype Distribution by Age of Remaining Invasive Pneumococcal Disease After Long-Term PCV10/13 Use: The PSERENADE Project
Maria Garcia Quesada et al.
Open Forum Infectious Diseases (2021)
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada et al.
MICROORGANISMS (2021)
Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13
Fabian Udden et al.
JOURNAL OF INFECTION (2021)
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
Shelly Senders et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012-2015)
Juan Carlos Sanz et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2020)
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018
Zahin Amin-Chowdhury et al.
CLINICAL INFECTIOUS DISEASES (2020)
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009-2017
Jose A. Suaya et al.
JOURNAL OF INFECTION (2020)
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency
Alessandra Lochen et al.
SCIENTIFIC REPORTS (2020)
Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe
C. Bonnave et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Making sense of differences in pneumococcal serotype replacement
Joseph A. Lewnard et al.
LANCET INFECTIOUS DISEASES (2019)
Indirect effects of paediatric conjugate vaccines on invasive pneumococcal disease in older adults
Pilar Ciruela et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France
Kostas Danis et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Pneumococcal conjugate vaccines in different settings
William P. Hausdorff
LANCET INFECTIOUS DISEASES (2019)
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000 June 30, 2016
Godwin Oligbu et al.
EMERGING INFECTIOUS DISEASES (2019)
The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects
Ioanna Papadatou et al.
VACCINES (2019)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Epidemiology of Otitis Media With Otorrhea Among Bangladeshi Children: Baseline Study for Future Assessment of Pneumococcal Conjugate Vaccine Impact
Hakka Naziat et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study
Jean-Pierre Bedos et al.
INTENSIVE CARE MEDICINE (2018)
Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains in the south of Tunisia: A five- year study (2012-2016) of pediatric and adult populations
Sonia Ktari et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines
Mitsuyo Kawaguchiya et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis
Evelyn Balsells et al.
PLOS ONE (2017)
Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014
C. Sheppard et al.
EUROSURVEILLANCE (2016)
Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013
Eun Young Cho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F
Alyssa R. Golden et al.
VACCINE (2016)
Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014
Satoshi Nakano et al.
VACCINE (2016)
Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands
Gertjan H. J. Wagenvoort et al.
VACCINE (2016)
Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Streptococcus pneumoniae: Serotype distribution, antimicrobial susceptibility, risk factors and mortality in Galicia over a two year-period
Susana Mendez-Lage et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children
Emmanuelle Varon et al.
VACCINE (2015)
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011
Wallis Rudnick et al.
VACCINE (2013)
Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999 2011
Sandra S. Richter et al.
EMERGING INFECTIOUS DISEASES (2013)
Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain
Asuncion Fenoll et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
Albert Jan van Hoek et al.
PLOS ONE (2012)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller et al.
LANCET INFECTIOUS DISEASES (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease
Inci Yildirim et al.
VACCINE (2010)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2007)
Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides
S van Selm et al.
INFECTION AND IMMUNITY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
